key: cord-0834625-z8udhmev
authors: Morgan, Paul; Shu, Chih-Wen
title: Molecular Dynamics Reveals the Effects of Temperature on Critical SARS-CoV-2 Proteins
date: 2021-01-26
journal: bioRxiv
DOI: 10.1101/2021.01.24.427990
sha: 6d548287cfe45b6fe1caaebb8a257bcbedabcd6c
doc_id: 834625
cord_uid: z8udhmev

Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) is a newly identified RNA virus that causes the serious infection Coronavirus Disease 2019 (COVID-19). The incidence of COVID-19 is still increasing worldwide despite the summer heat and cool winter. However, little is known about seasonal stability of SARS-CoV-2. Herein, we employ Molecular Dynamics (MD) simulations to explore the effect of temperature on four critical SARS-CoV-2 proteins. Our work demonstrates that the spike Receptor Binding Domain (RBD), Main protease (Mpro), and nonstructural protein 3 (macro X) possesses extreme thermos-stability when subjected to temperature variations rendering them attractive drug targets. Furthermore, our findings suggest that these four proteins are well adapted to habitable temperatures on earth and are largely insensitive to cold and warm climates. Furthermore, we report that the critical residues in SARS-CoV-2 RBD were less responsive to temperature variations as compared to the critical residues in SARS-CoV. As such, extreme summer and winter climates, and the transition between the two seasons, are expected to have a negligible effect on the stability of SARS-CoV-2 which will marginally suppress transmission rates until effective therapeutics are available world-wide.

demonstrates that the spike Receptor Binding Domain (RBD), Main protease (Mpro), and 23 nonstructural protein 3 (macro X) possesses extreme thermos-stability when subjected to 24 temperature variations rendering them attractive drug targets. Furthermore, our findings suggest 25 that these four proteins are well adapted to habitable temperatures on earth and are largely 26 insensitive to cold and warm climates. Furthermore, we report that the critical residues in SARS-

CoV-2 RBD were less responsive to temperature variations as compared to the critical residues in 28 SARS-CoV. As such, extreme summer and winter climates, and the transition between the two 29 seasons, are expected to have a negligible effect on the stability of SARS-CoV-2 which will 30 marginally suppress transmission rates until effective therapeutics are available world-wide. investigate the stability of SARS-CoV-2 in response to changes in temperature.

The SARS-CoV-2 genome is comprised of nearly 30,000 nucleotides. These nucleotides encodes 46 four structural proteins including the spike (S) protein, membrane (M) protein, envelope (E) 47 protein, and nucleocapsid (N) protein. 4, 5 The envelope glycoprotein spike (S) attaches to host cells 48 during infection through binding with Angiotensin-converting enzyme 2 (ACE-2). 6 The spike 49 glycoprotein is synthesized as a precursor and cleaved into two subunits, including S1 and S2. The 50 S1 contains the RBD, which has critical amino acids required for interaction with cellular ACE- Consequently, inhibiting Mpro can stall the production of viral particles and therefore suppress the 58 symptoms and severity of the COVID-19 infection.

The macro X domain is one of the most novel proteins of SARS-CoV-2 encoded by nonstructural 60 protein 3 (nsp3). 7 Nsp3 is a large multidomain membrane-bound protein, and its clearest role in 61 viral replication is cleaving the rep polyprotein. 7 Although the biological role of ADP-ribose 62 binding is still poorly understood, macro X domain is also a promising drug target. 7

Of all the structural proteins, the N protein is a highly immunogenic and abundantly expressed 64 during infection. 7 Although the SARS-CoV-2 S protein is currently being used as a leading target 65 antigen in vaccine development the complex mechanisms of viral entry lends itself to 66 complications in vaccine response. 7 In contrast to the SARS-CoV-2 S protein, the N gene is more 67 conserved and stable, with 90% amino acid homology and fewer mutations over time, also making 68 it an ideal drug target. 2,7

To date, the rate of infection worldwide has unarguably demonstrated that SARS-CoV-2 is quite 70 stable when subjected to cold and warm temperatures. 8 However, the effects of temperature on the 71 RBD, Mpro, macro X, and the nucleocapsid protein remains unclear and requires urgent clarity 72 with respect to their potential as stable drug targets. to equalize the total system charge. The steepest decent algorithm was used for initial energy 80 minimization until the system converged at Fmax 500 kJ/ (mol · nm). Water and ions were allowed 81 to equilibrate around the protein in two phases. The first phase of equilibration was at a constant 82 number of particles, volume, and temperature (NVT) while the second phase was at a constant 83 number of particles, pressure, and temperature (NPT). The system was allowed to equilibrate at a 84 reference temperature of 300 K, or reference pressure of 1 bar for 2.5 ps at a time step of 2 fs. The 

Relating RMSD and protein stability 98 Herein, we employ Molecular Dynamics (MD) simulations to assess the effect of temperature on 99 the SARS-CoV-2 RBD, Mpro, macro X and the nucleocapsid. We observed that subjecting the 100 proteins to changes in temperature, from 255K(-18°C) to 322K(49°C), which corresponds to the 101 transition from the peak of winter to the peak of summer. The videos for MD simulation of these 102 four proteins at temperature 255K and 322K were provided as supporting information. We found 103 that these four proteins had predominantly negligible effects as shown on the Root Mean Square 104 Deviation (RMSD) (Fig. S1-S4 ). RMSDs of Cα-atoms of a protein as a function of simulation time 105 give an estimate of the stability of protein structure. Macro X was demonstrated to be the most 106 thermo-stable protein with very negligible changes in average RMSD across the temperature series 107 (Fig. 1) . The nucleocapsid on the other hand, was the least thermos-stable protein with an average 108 RMSD of 2 Å across the temperature series. The RBD and Mpro had comparable stability 109 averaging 0.5 Å in RMSD (Fig. 1) .

It is also worthwhile noting that the nucleocapsid demonstrated the lowest average kinetic energy 111 (KE) across the temperature series while Mpro had the highest average KE. Macro X and the RBD 112 had comparable KE and were the least responsive when subjected to the temperature series. Our 113 findings suggest that the RBD, Mpro, and Maco X, are inherently thermos-stable, rendering them 114 ideal drug targets with potentially desirable drug binding kinetics. This is because secondary 

Next, we investigated the effect of temperature on the Root Mean Square Fluctuation (RMSF) of 120 the critical residues in the RBD. These residues are ultimately responsible for initializing the 121 interaction with ACE-2, the entry point for the infection of pneumocytes in the lungs. We report 122 that the critical residues in SARS-CoV-2 RBD were less responsive to temperature variations as 123 compared to the critical residues in SARS-CoV (Fig. 2) . It is worthwhile noting that the critical 124 residues are predominantly located on the subRBD of both strains. This is consistent with the 125 understanding that sequence regions involved in binding tend to show significant interspecific, 126 temperature-related differences in flexibility. 9

We further discriminated amongst the critical residues and inferred that L455, G482, and V483 This increased degree of rigidity in the SARS-CoV-2 subRBD, and, still yet, enigmatically 132 enhanced flexibility of the global RBD is perhaps a strategic evolutionary mutation that can at 133 minimum, partly explain the increased affinity and likely increased specificity for ACE-2.

Conventionally, it is understood that flexibility is positively correlated with specificity. 9-12 135 Whereas, increased rigidity is correlated with increased affinity. 12 Flexibility and affinity are 136 generally regarded as inverse correlates. 9,11,12 Thus, the elevated rigidity and reduced flexibility in 137 the SARS-CoV-2 subRBD might be the driving force behind the significantly enhanced increase 138 in affinity for ACE-2 (Fig. 3) . Likewise, the overall increase in globular flexibility of SARS-CoV-139 2 RBD may have far-reaching implications with regards to its specificity for ACE-2 (Fig. 3) . In conclusion, the evolution of SARS-CoV to SARS-CoV-2 suggests a complex evolutionary, 165 advantageous interplay that has resulted in this profound global pandemic (Fig 3.) . Furthermore, 166 the implications of our study suggests that four essential SARS-CoV-2 proteins are well adapted 167 to habitable temperatures on earth and exhibit extreme thermo-stability. 15 As a consequence, we 168 have thus far observed a negligible effect on the transmitability of SARS-CoV-2 with respect to 169 changes in temperature between the winter months and summer months. More importantly, our 170 study establishes a framework for elucidating stable promising drug targets for SARS-CoV-2.

We have confirmed this is an original work and has not been published elsewhere. The authorship 174 is limited to those who have made a significant contribution to the study as follows: PM and CWS 

Journal of 214 Computational Chemistry

and the nucleocapsid for a total 229 simulation time of 50 ns across a temperature series from 255K to 377K. (B) Depicts the corresponding 230 average kinetic energy of the globular proteins during the simulation. The RBD, Mpro, and Macro X 231 demonstrated the greatest thermo-stability across the temperature series. Shows the RMSF over 50 ns for 232 several critical residues in the (C) RBD of SARS-CoV-2 (D) RBD of SARS-CoV across a temperature 233 gradient from 0K to 377K. The critical residues in the SARS-CoV-2 sub